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Abstract
Background.Many cancer survivors experience late effects of
cancer treatment and therefore struggle to return to work. Norway
provides rehabilitation programs to increase labor force participa-
tion for cancer survivors after treatment. However, the extent to
which such programs affect labor force participation has not been
appropriately assessed. This study aims to investigate i) labor
force participation, sick leave and disability rates among cancer
survivors up to 10 years after being diagnosed with cancer and
identify comorbidities contributing to long-term sick leave or dis-
ability pensioning; ii) how type of cancer, treatment modalities,
employment sectors and financial- and sociodemographic factors
may influence labor force participation; iii) how participation in
rehabilitation programs among cancer survivor affect the long-
term labor force participation, the number of rehospitalizations
and incidence of comorbidities.
Design and methods. Information from four medical, welfare
and occupational registries in Norway will be linked to informa-
tion from 163,279 cancer cases (15.68 years old) registered in the
Norwegian Cancer Registry from 2004 to 2016. The registries
provide detailed information on disease characteristics, comor-
bidities, medical and surgical treatments, occupation, national
insurance benefits and demographics over a 10-year period fol-
lowing a diagnosis of cancer. 
Expected impact of the study for Public Health. The study will
provide important information on how treatment, rehabilitation
and sociodemographic factors influence labor force participation
among cancer survivors. Greater understanding of work-related
risk factors and the influence of rehabilitation on work-participa-
tion may encourage informed decisions among cancer patients,
healthcare and work professionals and service planners.  
Introduction
Cancer, late effects and ability to work
Europe has 3.2 million new cases of cancer each year, and 1
of 4 people will be diagnosed with cancer.1,2 Currently, more than
260,000 people who have or have had cancer live in Norway.
About 160,000 of these have survived 5 years or more after the
cancer diagnosis and can be described as long-term cancer sur-
Study Protocol
Significance for public health
This study could potentially determine the influence of cancer treatment, rehabilitation and sociodemographic factors on labour force participation and use
of social benefits and health care resources. Data from five nationwide medical, welfare and occupational registries from the whole cancer population in
Norway over a ten-year period following diagnosis will be analyzed. In addition, the study will expand the knowledge on risk factors for rehospitalization, sick
leave and disability, and provide important health-related, financial and sociodemographic information of patients referred to rehabilitation. The study has
the potential to provide solid evidence to guide treatment options and develop social benefit programs for a large and vulnerable patient population. 
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vivors.3 Cancer survivors are at risk of developing late effects that
can persist throughout life.4
Almost half of cancer survivors are of working age (15-65
years old).5 The prevalence of cancer survivors of working age is
expected to grow in industrialized countries because of ageing
populations, increasing retirement age and continuing improve-
ments in cancer treatment.1 Many cancer survivors experience per-
sisting side effects of treatment and struggle to return to work, and
are at risk of permanently leaving the labor force. Cognitive limi-
tations, coping issues, fatigue, depression and anxiety are reported
to influence ability to return to work.6 In addition, physical prob-
lems, such as difficulties with lifting and treatment-induced
menopausal symptoms, are frequently described to affect function-
ing at work.6 Cancer survivors with fatigue are also more likely to
experience reduced ability to work compared with age-matched
controls.7 A recently published systematic review showed that
impaired physical functioning negatively affectedreturn-to-work
and the ability to work among breast cancer survivors.8
Labor force participation after cancer
In general, work is good for people’s health, and especially for
mental health and quality of life.9 In addition, work is important to
secures income and good living conditions for the workers and
their families. Many cancer survivors have difficulties in returning
to work. Studies from both the United States and Europe have
shond that average return to work rates are ranging from 39% to
77% among all cancer survivors of working age.10 In addition, can-
cer survivors are 1.37 times more likely not to be employed than
healthy controls.5 Although studies indicate that the return to work
rate among cancer survivors has increased during recent years, the
success rate differs with the cancer site and treatment burden, with
early-stage breast cancer and cancer of the female reproductive
organs showing a better chance than lung cancer and gastrointesti-
nal cancer.11 Unfortunately, research on long-term labor force par-
ticipation (>5 years) among cancer survivors is scarce. Most stud-
ies have only investigated the return to work and not the extent to
which cancer survivors return to a sustainable and lasting work sit-
uation. Based on clinical experience, many people with cancer are
eager to return to work, but experience that they have to make
adjustments at work, are not able to work full time or have to
change work or occupation. It has been suggested that cancer sur-
vivors who return to work may not be able to stay in work for a
long period or that they over time have to make great changes in
work and/or occupation to achieve a sustainable work situation.12
Studies from Norway show that cancer survivors experience
reduced ability to carry out tasks and engage in paid work and
reduced energy to change to another job.13,14 Torp and associates
showed that the employment rate of women who survived cancer
declined over 5 years compared with a healthy control group, but
this did not apply to men who survived cancer.16 Nevertheless, the
sick leave rates of cancer survivors were constantly higher for both
male and female workers compared with the control group 5 years
after diagnosis.16 In another study in Norway, 26% of cancer sur-
vivors had to make adjustments in the workplace, and the most
common adjustment was reducing the number of working hours
per week.13 As a consequence, many cancer survivors face finan-
cial strain because of decreased labor force participation.17 The
cancer survivors receiving work allowance benefits after 1 year of
sick leave seem to especially report sustained reduced income.18
Most of the studies on work-related issues among people with can-
cer in Norway are rather dated.14-16,19 They therefore do not cover
the late effects of the most recent cancer treatments. In addition, no
studies have investigated labor force participation issues among
Norwegian cancer survivors at all ages (15-68 years) in a long-
term perspective (>5 years).
Factors affecting the labor force participation of
cancer survivors
Cancer is a heterogeneous disease with wide variation in treat-
ment modalities and late effects associated with the various diag-
noses and related treatments. Studies confirm that certain disease-
specific factors affect the ability to work to a greater extent than
others, but the conclusions are far from clear and precise.
Especially cancer survivors who have had chemotherapy often
change employment status or main occupation.10,20 Hauglann and
associates showed that people with breast cancer have a signifi-
cantly increased risk of receiving disability pension compared with
a cancer-free control group.21 Lung cancer, leukemia  and cancer
of the nervous system stand out as diagnoses that are associated
with an especially poor employment rate.1,15A meta-analysis
shows that labor force participation can present challenges for
groups with breast and head or neck cancer.5 In addition to diagno-
sis, tumor stage, cancer treatment and comorbidity decrease the
probability that cancer survivors return to work and maintain the
ability to work, especially for those who work in low-skilled
and/or physically demanding jobs.22
The studies on predictors of labor force participation among
cancer survivors in Norway  confirm the results in the international
studies showing negative effects of some diagnoses and of being
exposed to chemotherapy.16,23 However, one study using registry
data from Norway from 2000 to 2004 showed that socioeconomic
factors were more important for increased sick leave rates than
diagnosis, stage and treatment modalities.16 Nevertheless, this may
have changed in recent years because of changes in treatment
modalities and more severe or new types of late effects.
Work-related interventions to promote labor force
participation
A multidisciplinary approach is often used to support cancer
patients return to work process, work retention, work performance
and work satisfaction. This approach may include psychological,
physical, vocational, job placement services and vocational reha-
bilitation, occupational (such as educating employers and imple-
menting work adjustments) or legislative (such as antidiscrimina-
tion acts) interventions.1
The individual need for rehabilitation after cancer vary with
diagnosis according to the type of treatment, the severity of late
effects, sociodemographic factors, personality and vulnerability.
Multidimensional specialized rehabilitation programs are designed
to promote the coping and self-management abilities of people
with cancer.24 Both physical and psychosocial interventions are
combined in the same program to cover the various dimensions of
cancer rehabilitation. Importantly, several of the factors that are
associated with difficulty in labor force participation can be modi-
fied,24, and specialized multidisciplinary cancer rehabilitation rep-
resents a measure that can promote labor force participation among
cancer survivors.1
Norway has several rehabilitation programs within the special-
ist health care system for people with cancer, including both out-










patient and inpatient rehabilitation programs. Information about
who is referred to and use these rehabilitation services after a can-
cer diagnosis is very scare. Knowledge is lacking about the poten-
tial of these interventions to promote labor force participation. A
small study from Norway showed that  respectively 73% and 76%
of patients with breast and gynecological cancer returned to work
6 months after discharge from inpatient and outpatient rehabilita-
tion.24 However, the study did not include a control group of
patients who had not participated in rehabilitation and does not
allow to estimate treatment effect. In conclusion, there is insuffi-
cient evidence to conclude that rehabilitation after cancer has the
potential to promote labor force participation in Norway.
The impact of a rehabilitation on return to work and work par-
ticipation in a long-term perspective among cancer survivors
urgently needs to be investigated. We will therefore conduct a lon-
gitudinal prospective registry-based study called CANWORK
(Cancer and Work) to provide information on labor force partici-
pation, long-term sick leave and disability trajectories, risk factors
for not participating in the labor force and the efficiency of cancer
rehabilitation programs to promote labor force participation among
people with cancer.
Aims and hypotheses
This CANWORK study has four main aims: i) to investigate
labor force participation, sick leave and disability rates among can-
cer survivors up to 10 years after being diagnosed with cancer; ii)
to identify comorbidities contributing to long-term sick leave or
disability pensioning; iii) to investigate how the type of cancer,
treatment modalities, employment sectors and financial and
sociodemographic factors may influence labor force participation
after cancer diagnosis; iv) to assess how participating in rehabilita-
tion affects the long-term labor force participation, the number of
rehospitalizations and incidence of comorbidities of cancer sur-
vivors.  
We hypothesize that i) The labor force participation will
decrease over a 10 year period, while sick leave and  disability
rates increase during the same period. ii) The  key barriers to labor
force participation will include regional or metastatic cancer at
diagnosis,  comorbidities, age, adjuvant  therapy, education, living
with an employed partner and low income. iii) The participation in
multidisciplinary rehabilitation programs will increase labor force
participation and reduce sick leave and disability rates. 
Methodology
Study design
This is a prospective longitudinal cohort study based on health
and social data from public registries in Norway.
Study population
The study population comprises people with cancer of working
age (15-68 years) at the time of diagnosis (n=163,279) of both
sexes and with all cancer diagnoses from 2004 to 2016. When
applicable, the project will extract matched controls from data
including the remaining Norwegian population (about 3.5 million
subjects).
Data collection
The study will use the Norwegian Cancer Registry for enrol-
ment, and additional data will be retrieved through record linkage
with three mandatory national registries: the Norwegian Patient
Registry, Norwegian Prescription Database and Statistics
Norway/Norwegian Labor and Welfare Administration. 
The study will use data on employment contracts including
start and stop dates, contractual work hours and data on changes in
contractual work hours according to Statistics Norway‘s (the
national statistical institute of Norway) categorization.
Employment data from 1 year before diagnosis will be included.
Labor-force participation, number of rehospitalizations and preva-
lence of comorbidities are specific outcomes for the evaluation of
rehabilitation. Labor-force participation will be defined as being
employed during the 90 days prior to cancer diagnosis and at mea-
surement in a given time period (year, month) thereafter. In addi-
tion, working hours will be analyzed to investigate the influence
of rehabilitation on the amount of work particiapation beside hav-
ing a work contract. Working hours per week will be monitored
among the employed each year, divided into three categories: (a)
30 hours or more (full-time); (b) 20-29.9 hours (long part-time):
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Table 1. Source and type of data collected in the project.
Source of data                                     Type of data 
Norwegian Patient Registry                               Diagnoses for all diseases (ICD-10), treatment procedures for all diseases (NOMESCO Classification of Medical
                                                                                 Procedures, Norwegian Classification of Surgical Procedures, Anatomical Therapeutic Chemical Classification
                                                                                 System, cytostatic codes), treatment institution, rehabilitation institution, referring unit, rehabilitation scheme,
                                                                                 treatment and death.
                                                                                 Specifically for rehabilitation outcome: Incidence of comporbidities will be retrived based on number of diagnoses
                                                                                 registered on each patients. Number of re-hospitalizations after rehabilitation will be retrieved from Norwegian
                                                                                 Patient Registry.
Statistics Norway/Norwegian Labor                Employment status (having a work contract, working hours per week), sociodemographic and economic status,
and Welfare Administration registry               income for patient and household, cost of social benefit program, early retirement and loss of productivity and 
                                                                                 primary diagnosis (ICD-10) for social benefits.
Norwegian Cancer Registry                               Diagnosis, specific tumor information, specific tumor therapy, previous cancer treatment and comorbidities
Norwegian Prescription Database                   Drug use: drug name and active ingredient, quantity, strength, timing and costs
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(c) less than 20 hours (short part-time). A normal working week in
Norway is 37.5 hours per week. Number of re-hospitalizations
after rehabilitation will be retrieved and counted from the
Norwegian Patient Registry. This will include a combination of
information regarding acute care, inpatient rehabilitation and long-
term hospital stays. The prevalence of comorbidities will be calcu-
lated by information provided in the Norwegian Patient Registry
and Norwegian Prescription Database. Individual comorbidities
will be recorded and converted to comorbidity categories accord-
ing to the International Statistical Classification of Diseases and
Related Health Problems 10th Revision (ICD-10).
Sources and types of data
The registry sources and types of data are outlined in Table 1
and described further below. The project will use an authorized and
established data-linking infrastructure between the registries, and
the project group will receive a data file in which each person with
cancer is represented by a unique personal project serial number.
Thus, all data will be anonymized.
Disease- and treatment-specific variables
The disease- and treatment-specific variables will include
diagnosis (ICD-10 classification), date of diagnosis, number of
treatments, treatment status; type of treatment (surgery, chemother-
apy, radiation, hormone therapy), date of recurrence of cancer or
new cancer diagnosis, number of admissions to hospital, duration
of rehabilitation, type of rehabilitation program, drug use, previous
cancer treatment, comorbidities, cause and time of death and infor-
mation regarding geographical health care utilization. Cancer diag-
noses will be classified using the second topographic level of cat-
egorization according to the International Classification of
Diseases for Oncology, third edition.25
Demographic and socioeconomic data
The demographic and socioeconomic data will include sex,
age, number of children, children’s ages, cohabitation status, edu-
cation status, finances, income, employment sector, type of work
and other detailed variables. 
In official statistics from Statistics Norway, a reference week
in November is used to categorize individuals as employed, self-
employed or unemployed. Our data will include this. To capture all
employment, we will use data on employment contracts, including
start and stop dates as well as contractual work hours and data on
changes in contractual work hours.
Using data from Statistics Norway/Norwegian Labor and
Welfare Administration we will identify sickness spells among
employees and transitions into partial or full disability.
Statistical analysis
Alternative statistical approaches
We want to make causal inferences in investigating the aims of
the project. Traditionally, randomized controlled trials have been
viewed as the gold standard for exploring the effects of an inter-
vention. Given our research aims and data, a randomized con-
trolled trial is not feasible. However, numerous statistical tech-
niques have evolved to the point at which observational data are
used and recommended to perform natural or quasi-natural exper-
iments. In addition, in some settings, natural experiments may be
preferred over randomized controlled trials since they can generate
causal evidence with high external validity.26 The main challenge
of natural experiments is to ensure that the researcher has not
manipulated exposure. Thus, there is a possible, or even likely,
problem of selection bias. In natural experiments, it is possible to
control for both observed and unobserved confounding, which may
substantially reduce selection bias. Observed confounding can be
adjusted for through various matching techniques.27 To adjust for
unobservable confounding, a few techniques have been recom-
mended for epidemiology and health systems research: instrumen-
tal variables; regression discontinuity; interrupted time series; dif-
ference-in-differences and fixed-effects designs.28 Fixed-effects
designs are deemed useful when using registry data including
many respondents with regular and detailed collection over time29,
as in the registry data used in this project.
Challenges with a natural experiment
With available data covering a long time span we aim to use
some of the techniques mentioned above that would enable us to
reduce the bias caused by unobserved heterogeneity. When carry-
ing out a natural experiment or a quasi-natural experiment in
which two comparable groups have been subjected to two different
schemes during the period of study (such as cancer versus no can-
cer or rehabilitation versus no rehabilitation), the issue of endo-
geneity of cancer survivors’ enrollment in rehabilitation programs
must be correctly addressed. This is straightforwardly controlled
for in randomized controlled trials in which cancer survivors are
randomly assigned to a program. However, it has to be more
explicitly taken into account and controlled when the selection for
a program cannot be assumed to be independent of the observable
or unobservable employability characteristics of cancer survivors.
In this latter case, the selection bias (either self-selection by cancer
survivors themselves, selection of cancer survivors by employers
and health care professionals or a combination of these) could dra-
matically distort the estimated parameters. Moreover, in order not
to lose information provided by people who have been diagnosed
with cancer between 2004 and 2016 as controls (or non-treated)
and not cases (or treated) until the date of the cancer diagnosis,
dynamic treatment models will be considered.30
Difference-in-difference and fixed-effects regression
Difference-in-differences and fixed-effects regression can be
applied with a wide variety of regression models, and we will use
appropriate techniques to analyze the research questions in the pro-
ject. The most viable approach to answer research questions relat-
ed to sick leave rate, disability rate, prediction of sick leave and
disability and characteristics of the rehabilitation population is to
apply either a logit model with fixed effects or a linear probability
model with fixed effects to estimate the changes in rates over time.
We will do both to substantiate our results. In addition, we will also
consider using duration models (such as Cox regression) with
fixed effects. When fixed effects are used, it is not possible to esti-
mate the effect of time-invariant characteristics. Thus, we will ana-
lyze separate subgroups (such as by sex or by cancer diagnosis) to
describe pertinent differences between groups.
Fixed-effects analysis adjusts for all time-invariant character-
istics, and thus there is a reduced need for matching cases and con-
trols (when applicable). However, as a mean to further increase
comparability between cases and controls, we will apply matching
techniques (such as by means of propensity scores or direct match-
ing), possibly with time-varying characteristics. All analysis will
be two-sided, the level of significance will be set at p<0.05, and
analysis will mainly be performed using the statistics package
STATA.









Discussion and expected results of the study
The CANWORK study will evaluate long-term labor force
participation among cancer survivors and the impact of multidisci-
plinary rehabilitation programs on labor force participation in a
long-term perspective. Because of inadequate scientific evidence,
the recommendations for providing social support and cancer reha-
bilitation interventions are mostly based on short-term studies with
subpopulations of cancer survivors and often solely on the clinical
experience and interests of doctors and other health care
personnel.24,31 The CANWORK study has the potential to provide
solid evidence regarding the impact of multidisciplinary rehabilita-
tion on labor force participation, and the results can be important
for development of future clinical pathways for cancer survivors.
The results from the study may also expand the knowledge on the
incidence of comorbidities and how they influence cancer sur-
vivors’ labor force participation and the risk factors for rehospital-
ization, sick leave and disability. In addition, the study will also
provide information on the health-related, financial and sociode-
mographic characteristics of the people referred to rehabilitation.
A methodological challenge for registry-based research in
most countries is that linking data from nationwide registries with
health-related and socioeconomic variables is prohibited.
However, in the Nordic countries, linking data between registries
based on a personal identification number is legal and practically
possible. The Nordic registry infrastructure therefore represents an
important advantage for longitudinal research in health, welfare
and working life for designing public policies. The epidemiologi-
cal approach to be used in this project has contributed to major sci-
entific discoveries between risk factors and cancer and is consid-
ered a very solid method, since it enables analysis with integration
of factors from several social and health-related fields in a large
group of people with cancer over a longer period. In this study, the
sample size of people with cancer and the large dataset enable
methods to be applied to detect underlying processes that predict
labor force participation. In addition, access to large data sets of
the general population will help to extract well-defined groups
matched by age, sex and other socioeconomic variables.
Nevertheless, the observational nature of much epidemiological
research has drawn criticism including “excess expense, repudiat-
ed findings, studies that offer small incremental knowledge, inabil-
ity to innovate at reasonable cost and failure to identify research
questions with the greatest merit”.32 This project therefore has a
clear strategy to extend the collection of epidemiological research
beyond discovery and causal research to include multilevel analy-
sis of socioeconomic context and evaluation of health care inter-
ventions and implementation of social benefit programs. By
enabling a high degree of transparency and interdisciplinary col-
laboration, the CANWORK study will exploit the advantages of
Norway’s registry structure to provide a strong scientific founda-
tion, which hopefully will accelerate the translation of the scientif-
ic discoveries into health benefits for people with cancer. 
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